Pathogenesis of Endometriosis: New Insights into Prospective Therapies

Endometriosis is a female reproductive disorder characterized by growth of uterine cells and tissue in distant sites. Around 2–10% of women experience this condition during reproductive age, 35–50% of whom encounter fertility issues or pain. To date, there are no established methods for its early di...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Radhika Kapoor, Christina Anna Stratopoulou, Marie-Madeleine Dolmans
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/10c299029b4c40ab8cf388fdc48de384
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:10c299029b4c40ab8cf388fdc48de384
record_format dspace
spelling oai:doaj.org-article:10c299029b4c40ab8cf388fdc48de3842021-11-11T17:09:38ZPathogenesis of Endometriosis: New Insights into Prospective Therapies10.3390/ijms2221117001422-00671661-6596https://doaj.org/article/10c299029b4c40ab8cf388fdc48de3842021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11700https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Endometriosis is a female reproductive disorder characterized by growth of uterine cells and tissue in distant sites. Around 2–10% of women experience this condition during reproductive age, 35–50% of whom encounter fertility issues or pain. To date, there are no established methods for its early diagnosis and treatment, other than surgical procedures and scans. It is difficult to identify the disease at its onset, unless symptoms such as infertility and/or pain are present. Determining the mechanisms involved in its pathogenesis is vital, not only to pave the way for early identification, but also for disease management and development of less invasive but successful treatment strategies. Endometriosis is characterized by cell proliferation, propagation, evasion of immunosurveillance, and invasive metastasis. This review reports the underlying mechanisms that are individually or collectively responsible for disease establishment and evolution. Treatment of endometriosis mainly involves hormone therapies, which may be undesirable or have their own repercussions. It is therefore important to devise alternative strategies that are both effective and cause fewer side effects. Use of phytochemicals may be one of them. This review focuses on pharmacological inhibitors that can be therapeutically investigated in terms of their effects on signaling pathways and/or mechanisms involved in the pathogenesis of endometriosis.Radhika KapoorChristina Anna StratopoulouMarie-Madeleine DolmansMDPI AGarticleendometriosispathogenesisinflammationestrogen signalingapoptosisepithelial–mesenchymal transitionBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11700, p 11700 (2021)
institution DOAJ
collection DOAJ
language EN
topic endometriosis
pathogenesis
inflammation
estrogen signaling
apoptosis
epithelial–mesenchymal transition
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle endometriosis
pathogenesis
inflammation
estrogen signaling
apoptosis
epithelial–mesenchymal transition
Biology (General)
QH301-705.5
Chemistry
QD1-999
Radhika Kapoor
Christina Anna Stratopoulou
Marie-Madeleine Dolmans
Pathogenesis of Endometriosis: New Insights into Prospective Therapies
description Endometriosis is a female reproductive disorder characterized by growth of uterine cells and tissue in distant sites. Around 2–10% of women experience this condition during reproductive age, 35–50% of whom encounter fertility issues or pain. To date, there are no established methods for its early diagnosis and treatment, other than surgical procedures and scans. It is difficult to identify the disease at its onset, unless symptoms such as infertility and/or pain are present. Determining the mechanisms involved in its pathogenesis is vital, not only to pave the way for early identification, but also for disease management and development of less invasive but successful treatment strategies. Endometriosis is characterized by cell proliferation, propagation, evasion of immunosurveillance, and invasive metastasis. This review reports the underlying mechanisms that are individually or collectively responsible for disease establishment and evolution. Treatment of endometriosis mainly involves hormone therapies, which may be undesirable or have their own repercussions. It is therefore important to devise alternative strategies that are both effective and cause fewer side effects. Use of phytochemicals may be one of them. This review focuses on pharmacological inhibitors that can be therapeutically investigated in terms of their effects on signaling pathways and/or mechanisms involved in the pathogenesis of endometriosis.
format article
author Radhika Kapoor
Christina Anna Stratopoulou
Marie-Madeleine Dolmans
author_facet Radhika Kapoor
Christina Anna Stratopoulou
Marie-Madeleine Dolmans
author_sort Radhika Kapoor
title Pathogenesis of Endometriosis: New Insights into Prospective Therapies
title_short Pathogenesis of Endometriosis: New Insights into Prospective Therapies
title_full Pathogenesis of Endometriosis: New Insights into Prospective Therapies
title_fullStr Pathogenesis of Endometriosis: New Insights into Prospective Therapies
title_full_unstemmed Pathogenesis of Endometriosis: New Insights into Prospective Therapies
title_sort pathogenesis of endometriosis: new insights into prospective therapies
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/10c299029b4c40ab8cf388fdc48de384
work_keys_str_mv AT radhikakapoor pathogenesisofendometriosisnewinsightsintoprospectivetherapies
AT christinaannastratopoulou pathogenesisofendometriosisnewinsightsintoprospectivetherapies
AT mariemadeleinedolmans pathogenesisofendometriosisnewinsightsintoprospectivetherapies
_version_ 1718432161775747072